| R-HSA-109581 |
Apoptosis |
| R-HSA-110312 |
Translesion synthesis by REV1 |
| R-HSA-110313 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template |
| R-HSA-110314 |
Recognition of DNA damage by PCNA-containing replication complex |
| R-HSA-110320 |
Translesion Synthesis by POLH |
| R-HSA-1168372 |
Downstream signaling events of B Cell Receptor (BCR) |
| R-HSA-1169091 |
Activation of NF-kappaB in B cells |
| R-HSA-1169408 |
ISG15 antiviral mechanism |
| R-HSA-1169410 |
Antiviral mechanism by IFN-stimulated genes |
| R-HSA-1227986 |
Signaling by ERBB2 |
| R-HSA-1234174 |
Cellular response to hypoxia |
| R-HSA-1234176 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha |
| R-HSA-1236382 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants |
| R-HSA-1236394 |
Signaling by ERBB4 |
| R-HSA-1236974 |
ER-Phagosome pathway |
| R-HSA-1236975 |
Antigen processing-Cross presentation |
| R-HSA-1253288 |
Downregulation of ERBB4 signaling |
| R-HSA-1257604 |
PIP3 activates AKT signaling |
| R-HSA-1266738 |
Developmental Biology |
| R-HSA-1266738 |
Developmental Biology |
| R-HSA-1280215 |
Cytokine Signaling in Immune system |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1295596 |
Spry regulation of FGF signaling |
| R-HSA-1358803 |
Downregulation of ERBB2:ERBB3 signaling |
| R-HSA-1430728 |
Metabolism |
| R-HSA-157118 |
Signaling by NOTCH |
| R-HSA-157118 |
Signaling by NOTCH |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162587 |
HIV Life Cycle |
| R-HSA-162588 |
Budding and maturation of HIV virion |
| R-HSA-162599 |
Late Phase of HIV Life Cycle |
| R-HSA-162906 |
HIV Infection |
| R-HSA-162909 |
Host Interactions of HIV factors |
| R-HSA-1632852 |
Macroautophagy |
| R-HSA-1632852 |
Macroautophagy |
| R-HSA-1640170 |
Cell Cycle |
| R-HSA-1643685 |
Disease |
| R-HSA-1643685 |
Disease |
| R-HSA-1643713 |
Signaling by EGFR in Cancer |
| R-HSA-166016 |
Toll Like Receptor 4 (TLR4) Cascade |
| R-HSA-166058 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane |
| R-HSA-166166 |
MyD88-independent TLR4 cascade |
| R-HSA-168138 |
Toll Like Receptor 9 (TLR9) Cascade |
| R-HSA-168142 |
Toll Like Receptor 10 (TLR10) Cascade |
| R-HSA-168164 |
Toll Like Receptor 3 (TLR3) Cascade |
| R-HSA-168176 |
Toll Like Receptor 5 (TLR5) Cascade |
| R-HSA-168179 |
Toll Like Receptor TLR1:TLR2 Cascade |
| R-HSA-168181 |
Toll Like Receptor 7/8 (TLR7/8) Cascade |
| R-HSA-168188 |
Toll Like Receptor TLR6:TLR2 Cascade |
| R-HSA-168249 |
Innate Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-168638 |
NOD1/2 Signaling Pathway |
| R-HSA-168643 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| R-HSA-168898 |
Toll-like Receptor Cascades |
| R-HSA-168927 |
TICAM1, RIP1-mediated IKK complex recruitment |
| R-HSA-168928 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta |
| R-HSA-169911 |
Regulation of Apoptosis |
| R-HSA-170834 |
Signaling by TGF-beta Receptor Complex |
| R-HSA-170834 |
Signaling by TGF-beta Receptor Complex |
| R-HSA-174048 |
APC/C:Cdc20 mediated degradation of Cyclin B |
| R-HSA-174084 |
Autodegradation of Cdh1 by Cdh1:APC/C |
| R-HSA-174113 |
SCF-beta-TrCP mediated degradation of Emi1 |
| R-HSA-174143 |
APC/C-mediated degradation of cell cycle proteins |
| R-HSA-174154 |
APC/C:Cdc20 mediated degradation of Securin |
| R-HSA-174178 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| R-HSA-174184 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A |
| R-HSA-174490 |
Membrane binding and targetting of GAG proteins |
| R-HSA-174495 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins |
| R-HSA-175474 |
Assembly Of The HIV Virion |
| R-HSA-176408 |
Regulation of APC/C activators between G1/S and early anaphase |
| R-HSA-176409 |
APC/C:Cdc20 mediated degradation of mitotic proteins |
| R-HSA-176814 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins |
| R-HSA-177929 |
Signaling by EGFR |
| R-HSA-179409 |
APC-Cdc20 mediated degradation of Nek2A |
| R-HSA-179419 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint |
| R-HSA-180534 |
Vpu mediated degradation of CD4 |
| R-HSA-180585 |
Vif-mediated degradation of APOBEC3G |
| R-HSA-181438 |
Toll Like Receptor 2 (TLR2) Cascade |
| R-HSA-182971 |
EGFR downregulation |
| R-HSA-1834949 |
Cytosolic sensors of pathogen-associated DNA |
| R-HSA-187577 |
SCF(Skp2)-mediated degradation of p27/p21 |
| R-HSA-190236 |
Signaling by FGFR |
| R-HSA-193639 |
p75NTR signals via NF-kB |
| R-HSA-193704 |
p75 NTR receptor-mediated signalling |
| R-HSA-195253 |
Degradation of beta-catenin by the destruction complex |
| R-HSA-195721 |
Signaling by WNT |
| R-HSA-1980143 |
Signaling by NOTCH1 |
| R-HSA-1980143 |
Signaling by NOTCH1 |
| R-HSA-1980145 |
Signaling by NOTCH2 |
| R-HSA-199991 |
Membrane Trafficking |
| R-HSA-201681 |
TCF dependent signaling in response to WNT |
| R-HSA-202403 |
TCR signaling |
| R-HSA-202424 |
Downstream TCR signaling |
| R-HSA-204998 |
Cell death signalling via NRAGE, NRIF and NADE |
| R-HSA-205043 |
NRIF signals cell death from the nucleus |
| R-HSA-209543 |
p75NTR recruits signalling complexes |
| R-HSA-209560 |
NF-kB is activated and signals survival |
| R-HSA-211733 |
Regulation of activated PAK-2p34 by proteasome mediated degradation |
| R-HSA-2122947 |
NOTCH1 Intracellular Domain Regulates Transcription |
| R-HSA-2122948 |
Activated NOTCH1 Transmits Signal to the Nucleus |
| R-HSA-2122948 |
Activated NOTCH1 Transmits Signal to the Nucleus |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-2173788 |
Downregulation of TGF-beta receptor signaling |
| R-HSA-2173788 |
Downregulation of TGF-beta receptor signaling |
| R-HSA-2173789 |
TGF-beta receptor signaling activates SMADs |
| R-HSA-2173789 |
TGF-beta receptor signaling activates SMADs |
| R-HSA-2173791 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| R-HSA-2173793 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| R-HSA-2173793 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| R-HSA-2173795 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| R-HSA-2173795 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| R-HSA-2173796 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| R-HSA-2173796 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| R-HSA-2262752 |
Cellular responses to stress |
| R-HSA-2454202 |
Fc epsilon receptor (FCERI) signaling |
| R-HSA-2467813 |
Separation of Sister Chromatids |
| R-HSA-2555396 |
Mitotic Metaphase and Anaphase |
| R-HSA-2559580 |
Oxidative Stress Induced Senescence |
| R-HSA-2559582 |
Senescence-Associated Secretory Phenotype (SASP) |
| R-HSA-2559583 |
Cellular Senescence |
| R-HSA-2559585 |
Oncogene Induced Senescence |
| R-HSA-2565942 |
Regulation of PLK1 Activity at G2/M Transition |
| R-HSA-2644602 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer |
| R-HSA-2644603 |
Signaling by NOTCH1 in Cancer |
| R-HSA-2644606 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants |
| R-HSA-2672351 |
Stimuli-sensing channels |
| R-HSA-2691230 |
Signaling by NOTCH1 HD Domain Mutants in Cancer |
| R-HSA-2691232 |
Constitutive Signaling by NOTCH1 HD Domain Mutants |
| R-HSA-2871837 |
FCERI mediated NF-kB activation |
| R-HSA-2894858 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer |
| R-HSA-2894862 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants |
| R-HSA-2979096 |
NOTCH2 Activation and Transmission of Signal to the Nucleus |
| R-HSA-3134975 |
Regulation of innate immune responses to cytosolic DNA |
| R-HSA-3229121 |
Glycogen storage diseases |
| R-HSA-3322077 |
Glycogen synthesis |
| R-HSA-349425 |
Autodegradation of the E3 ubiquitin ligase COP1 |
| R-HSA-3700989 |
Transcriptional Regulation by TP53 |
| R-HSA-376176 |
Signaling by ROBO receptors |
| R-HSA-376176 |
Signaling by ROBO receptors |
| R-HSA-3769402 |
Deactivation of the beta-catenin transactivating complex |
| R-HSA-3785653 |
Myoclonic epilepsy of Lafora |
| R-HSA-382551 |
Transport of small molecules |
| R-HSA-382556 |
ABC-family proteins mediated transport |
| R-HSA-3858494 |
Beta-catenin independent WNT signaling |
| R-HSA-392499 |
Metabolism of proteins |
| R-HSA-392499 |
Metabolism of proteins |
| R-HSA-400253 |
Circadian Clock |
| R-HSA-4086400 |
PCP/CE pathway |
| R-HSA-422475 |
Axon guidance |
| R-HSA-422475 |
Axon guidance |
| R-HSA-445989 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| R-HSA-446203 |
Asparagine N-linked glycosylation |
| R-HSA-446652 |
Interleukin-1 family signaling |
| R-HSA-448424 |
Interleukin-17 signaling |
| R-HSA-449147 |
Signaling by Interleukins |
| R-HSA-450294 |
MAP kinase activation |
| R-HSA-450302 |
activated TAK1 mediates p38 MAPK activation |
| R-HSA-450321 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| R-HSA-450408 |
AUF1 (hnRNP D0) binds and destabilizes mRNA |
| R-HSA-450531 |
Regulation of mRNA stability by proteins that bind AU-rich elements |
| R-HSA-453274 |
Mitotic G2-G2/M phases |
| R-HSA-453276 |
Regulation of mitotic cell cycle |
| R-HSA-453279 |
Mitotic G1 phase and G1/S transition |
| R-HSA-4608870 |
Asymmetric localization of PCP proteins |
| R-HSA-4641257 |
Degradation of AXIN |
| R-HSA-4641258 |
Degradation of DVL |
| R-HSA-4641263 |
Regulation of FZD by ubiquitination |
| R-HSA-512988 |
Interleukin-3, Interleukin-5 and GM-CSF signaling |
| R-HSA-5205647 |
Mitophagy |
| R-HSA-5205685 |
PINK1-PRKN Mediated Mitophagy |
| R-HSA-5213460 |
RIPK1-mediated regulated necrosis |
| R-HSA-5218859 |
Regulated Necrosis |
| R-HSA-532668 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| R-HSA-5357801 |
Programmed Cell Death |
| R-HSA-5357801 |
Programmed Cell Death |
| R-HSA-5357905 |
Regulation of TNFR1 signaling |
| R-HSA-5357956 |
TNFR1-induced NFkappaB signaling pathway |
| R-HSA-5358346 |
Hedgehog ligand biogenesis |
| R-HSA-5358351 |
Signaling by Hedgehog |
| R-HSA-5358351 |
Signaling by Hedgehog |
| R-HSA-5362768 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD |
| R-HSA-5387390 |
Hh mutants abrogate ligand secretion |
| R-HSA-5607761 |
Dectin-1 mediated noncanonical NF-kB signaling |
| R-HSA-5607764 |
CLEC7A (Dectin-1) signaling |
| R-HSA-5610780 |
Degradation of GLI1 by the proteasome |
| R-HSA-5610783 |
Degradation of GLI2 by the proteasome |
| R-HSA-5610785 |
GLI3 is processed to GLI3R by the proteasome |
| R-HSA-5610787 |
Hedgehog 'off' state |
| R-HSA-5610787 |
Hedgehog 'off' state |
| R-HSA-5619084 |
ABC transporter disorders |
| R-HSA-5619115 |
Disorders of transmembrane transporters |
| R-HSA-5621481 |
C-type lectin receptors (CLRs) |
| R-HSA-5632684 |
Hedgehog 'on' state |
| R-HSA-5632684 |
Hedgehog 'on' state |
| R-HSA-5633007 |
Regulation of TP53 Activity |
| R-HSA-5637815 |
Signaling by Ligand-Responsive EGFR Variants in Cancer |
| R-HSA-5653656 |
Vesicle-mediated transport |
| R-HSA-5654726 |
Negative regulation of FGFR1 signaling |
| R-HSA-5654727 |
Negative regulation of FGFR2 signaling |
| R-HSA-5654732 |
Negative regulation of FGFR3 signaling |
| R-HSA-5654733 |
Negative regulation of FGFR4 signaling |
| R-HSA-5654736 |
Signaling by FGFR1 |
| R-HSA-5654738 |
Signaling by FGFR2 |
| R-HSA-5654741 |
Signaling by FGFR3 |
| R-HSA-5654743 |
Signaling by FGFR4 |
| R-HSA-5655862 |
Translesion synthesis by POLK |
| R-HSA-5656121 |
Translesion synthesis by POLI |
| R-HSA-5656169 |
Termination of translesion DNA synthesis |
| R-HSA-5658442 |
Regulation of RAS by GAPs |
| R-HSA-5663084 |
Diseases of carbohydrate metabolism |
| R-HSA-5663202 |
Diseases of signal transduction by growth factor receptors and second messengers |
| R-HSA-5663205 |
Infectious disease |
| R-HSA-5663205 |
Infectious disease |
| R-HSA-5668541 |
TNFR2 non-canonical NF-kB pathway |
| R-HSA-5668914 |
Diseases of metabolism |
| R-HSA-5673001 |
RAF/MAP kinase cascade |
| R-HSA-5675221 |
Negative regulation of MAPK pathway |
| R-HSA-5675482 |
Regulation of necroptotic cell death |
| R-HSA-5676590 |
NIK-->noncanonical NF-kB signaling |
| R-HSA-5678895 |
Defective CFTR causes cystic fibrosis |
| R-HSA-5683057 |
MAPK family signaling cascades |
| R-HSA-5684264 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation |
| R-HSA-5684996 |
MAPK1/MAPK3 signaling |
| R-HSA-5685942 |
HDR through Homologous Recombination (HRR) |
| R-HSA-5687128 |
MAPK6/MAPK4 signaling |
| R-HSA-5688426 |
Deubiquitination |
| R-HSA-5688426 |
Deubiquitination |
| R-HSA-5689603 |
UCH proteinases |
| R-HSA-5689603 |
UCH proteinases |
| R-HSA-5689877 |
Josephin domain DUBs |
| R-HSA-5689880 |
Ub-specific processing proteases |
| R-HSA-5689896 |
Ovarian tumor domain proteases |
| R-HSA-5689901 |
Metalloprotease DUBs |
| R-HSA-5693532 |
DNA Double-Strand Break Repair |
| R-HSA-5693538 |
Homology Directed Repair |
| R-HSA-5693565 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks |
| R-HSA-5693567 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) |
| R-HSA-5693606 |
DNA Double Strand Break Response |
| R-HSA-5693607 |
Processing of DNA double-strand break ends |
| R-HSA-5696394 |
DNA Damage Recognition in GG-NER |
| R-HSA-5696395 |
Formation of Incision Complex in GG-NER |
| R-HSA-5696397 |
Gap-filling DNA repair synthesis and ligation in GG-NER |
| R-HSA-5696398 |
Nucleotide Excision Repair |
| R-HSA-5696399 |
Global Genome Nucleotide Excision Repair (GG-NER) |
| R-HSA-5696400 |
Dual Incision in GG-NER |
| R-HSA-597592 |
Post-translational protein modification |
| R-HSA-597592 |
Post-translational protein modification |
| R-HSA-6781823 |
Formation of TC-NER Pre-Incision Complex |
| R-HSA-6781827 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) |
| R-HSA-6782135 |
Dual incision in TC-NER |
| R-HSA-6782210 |
Gap-filling DNA repair synthesis and ligation in TC-NER |
| R-HSA-6783310 |
Fanconi Anemia Pathway |
| R-HSA-6804756 |
Regulation of TP53 Activity through Phosphorylation |
| R-HSA-6804757 |
Regulation of TP53 Degradation |
| R-HSA-6804760 |
Regulation of TP53 Activity through Methylation |
| R-HSA-6806003 |
Regulation of TP53 Expression and Degradation |
| R-HSA-6806834 |
Signaling by MET |
| R-HSA-6807004 |
Negative regulation of MET activity |
| R-HSA-6807070 |
PTEN Regulation |
| R-HSA-68827 |
CDT1 association with the CDC6:ORC:origin complex |
| R-HSA-68867 |
Assembly of the pre-replicative complex |
| R-HSA-68882 |
Mitotic Anaphase |
| R-HSA-68886 |
M Phase |
| R-HSA-68949 |
Orc1 removal from chromatin |
| R-HSA-69002 |
DNA Replication Pre-Initiation |
| R-HSA-69017 |
CDK-mediated phosphorylation and removal of Cdc6 |
| R-HSA-69052 |
Switching of origins to a post-replicative state |
| R-HSA-69202 |
Cyclin E associated events during G1/S transition |
| R-HSA-69206 |
G1/S Transition |
| R-HSA-69231 |
Cyclin D associated events in G1 |
| R-HSA-69236 |
G1 Phase |
| R-HSA-69239 |
Synthesis of DNA |
| R-HSA-69242 |
S Phase |
| R-HSA-69275 |
G2/M Transition |
| R-HSA-69278 |
Cell Cycle, Mitotic |
| R-HSA-69306 |
DNA Replication |
| R-HSA-69481 |
G2/M Checkpoints |
| R-HSA-69541 |
Stabilization of p53 |
| R-HSA-69563 |
p53-Dependent G1 DNA Damage Response |
| R-HSA-69580 |
p53-Dependent G1/S DNA damage checkpoint |
| R-HSA-69601 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A |
| R-HSA-69610 |
p53-Independent DNA Damage Response |
| R-HSA-69613 |
p53-Independent G1/S DNA damage checkpoint |
| R-HSA-69615 |
G1/S DNA Damage Checkpoints |
| R-HSA-69620 |
Cell Cycle Checkpoints |
| R-HSA-69656 |
Cyclin A:Cdk2-associated events at S phase entry |
| R-HSA-71387 |
Metabolism of carbohydrates |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-73887 |
Death Receptor Signalling |
| R-HSA-73893 |
DNA Damage Bypass |
| R-HSA-73894 |
DNA Repair |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-75815 |
Ubiquitin-dependent degradation of Cyclin D |
| R-HSA-75893 |
TNF signaling |
| R-HSA-8848021 |
Signaling by PTK6 |
| R-HSA-8849469 |
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 |
| R-HSA-8852135 |
Protein ubiquitination |
| R-HSA-8852135 |
Protein ubiquitination |
| R-HSA-8852276 |
The role of GTSE1 in G2/M progression after G2 checkpoint |
| R-HSA-8854050 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis |
| R-HSA-8856825 |
Cargo recognition for clathrin-mediated endocytosis |
| R-HSA-8856828 |
Clathrin-mediated endocytosis |
| R-HSA-8863795 |
Downregulation of ERBB2 signaling |
| R-HSA-8866652 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes |
| R-HSA-8866652 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes |
| R-HSA-8866654 |
E3 ubiquitin ligases ubiquitinate target proteins |
| R-HSA-8875360 |
InlB-mediated entry of Listeria monocytogenes into host cell |
| R-HSA-8875360 |
InlB-mediated entry of Listeria monocytogenes into host cell |
| R-HSA-8876384 |
Listeria monocytogenes entry into host cells |
| R-HSA-8876384 |
Listeria monocytogenes entry into host cells |
| R-HSA-8876493 |
InlA-mediated entry of Listeria monocytogenes into host cells |
| R-HSA-8878159 |
Transcriptional regulation by RUNX3 |
| R-HSA-8878166 |
Transcriptional regulation by RUNX2 |
| R-HSA-8878166 |
Transcriptional regulation by RUNX2 |
| R-HSA-8878171 |
Transcriptional regulation by RUNX1 |
| R-HSA-8939236 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs |
| R-HSA-8939902 |
Regulation of RUNX2 expression and activity |
| R-HSA-8939902 |
Regulation of RUNX2 expression and activity |
| R-HSA-8941858 |
Regulation of RUNX3 expression and activity |
| R-HSA-8948747 |
Regulation of PTEN localization |
| R-HSA-8948751 |
Regulation of PTEN stability and activity |
| R-HSA-8951664 |
Neddylation |
| R-HSA-8953854 |
Metabolism of RNA |
| R-HSA-8953897 |
Cellular responses to external stimuli |
| R-HSA-8982491 |
Glycogen metabolism |
| R-HSA-9006925 |
Intracellular signaling by second messengers |
| R-HSA-9006927 |
Signaling by Non-Receptor Tyrosine Kinases |
| R-HSA-9006934 |
Signaling by Receptor Tyrosine Kinases |
| R-HSA-9006936 |
Signaling by TGFB family members |
| R-HSA-9006936 |
Signaling by TGFB family members |
| R-HSA-901032 |
ER Quality Control Compartment (ERQC) |
| R-HSA-901042 |
Calnexin/calreticulin cycle |
| R-HSA-9010553 |
Regulation of expression of SLITs and ROBOs |
| R-HSA-9010553 |
Regulation of expression of SLITs and ROBOs |
| R-HSA-9012852 |
Signaling by NOTCH3 |
| R-HSA-9012852 |
Signaling by NOTCH3 |
| R-HSA-9013507 |
NOTCH3 Activation and Transmission of Signal to the Nucleus |
| R-HSA-9013507 |
NOTCH3 Activation and Transmission of Signal to the Nucleus |
| R-HSA-9013694 |
Signaling by NOTCH4 |
| R-HSA-9013973 |
TICAM1-dependent activation of IRF3/IRF7 |
| R-HSA-9014325 |
TICAM1,TRAF6-dependent induction of TAK1 complex |
| R-HSA-9020702 |
Interleukin-1 signaling |
| R-HSA-9033241 |
Peroxisomal protein import |
| R-HSA-9033241 |
Peroxisomal protein import |
| R-HSA-912631 |
Regulation of signaling by CBL |
| R-HSA-913531 |
Interferon Signaling |
| R-HSA-917729 |
Endosomal Sorting Complex Required For Transport (ESCRT) |
| R-HSA-917937 |
Iron uptake and transport |
| R-HSA-936440 |
Negative regulators of DDX58/IFIH1 signaling |
| R-HSA-936964 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| R-HSA-937039 |
IRAK1 recruits IKK complex |
| R-HSA-937041 |
IKK complex recruitment mediated by RIP1 |
| R-HSA-937042 |
IRAK2 mediated activation of TAK1 complex |
| R-HSA-937061 |
TRIF(TICAM1)-mediated TLR4 signaling |
| R-HSA-937072 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex |
| R-HSA-9604323 |
Negative regulation of NOTCH4 signaling |
| R-HSA-9607240 |
FLT3 Signaling |
| R-HSA-9609507 |
Protein localization |
| R-HSA-9609507 |
Protein localization |
| R-HSA-9612973 |
Autophagy |
| R-HSA-9612973 |
Autophagy |
| R-HSA-9613829 |
Chaperone Mediated Autophagy |
| R-HSA-9615710 |
Late endosomal microautophagy |
| R-HSA-9635486 |
Infection with Mycobacterium tuberculosis |
| R-HSA-9636383 |
Prevention of phagosomal-lysosomal fusion |
| R-HSA-9637628 |
Modulation by Mtb of host immune system |
| R-HSA-9637687 |
Suppression of phagosomal maturation |
| R-HSA-9637690 |
Response of Mtb to phagocytosis |
| R-HSA-9645460 |
Alpha-protein kinase 1 signaling pathway |
| R-HSA-9646399 |
Aggrephagy |
| R-HSA-9646399 |
Aggrephagy |
| R-HSA-9648002 |
RAS processing |
| R-HSA-9663891 |
Selective autophagy |
| R-HSA-9663891 |
Selective autophagy |
| R-HSA-9664873 |
Pexophagy |
| R-HSA-9675108 |
Nervous system development |
| R-HSA-9675108 |
Nervous system development |
| R-HSA-9678108 |
SARS-CoV-1 Infection |
| R-HSA-9679506 |
SARS-CoV Infections |
| R-HSA-9679506 |
SARS-CoV Infections |
| R-HSA-9683683 |
Maturation of protein E |
| R-HSA-9683701 |
Translation of structural proteins |
| R-HSA-9694493 |
Maturation of protein E |
| R-HSA-9694516 |
SARS-CoV-2 Infection |
| R-HSA-9694635 |
Translation of structural proteins |
| R-HSA-975110 |
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| R-HSA-975138 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
| R-HSA-975144 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation |
| R-HSA-975155 |
MyD88 dependent cascade initiated on endosome |
| R-HSA-975163 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| R-HSA-975871 |
MyD88 cascade initiated on plasma membrane |
| R-HSA-977225 |
Amyloid fiber formation |
| R-HSA-983168 |
Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-983169 |
Class I MHC mediated antigen processing & presentation |
| R-HSA-983169 |
Class I MHC mediated antigen processing & presentation |
| R-HSA-983705 |
Signaling by the B Cell Receptor (BCR) |
| R-HSA-983712 |
Ion channel transport |
